CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A case of combined hyperlipoproteinemia.
Young Bae Kwon, Sung Hee Ihm, Moon Ki Choi, Byung Tae Kim, Yeon Bok Jang, Sung Woo Park
Endocrinol Metab. 1991;6(2):191-195.   Published online January 1, 2001

Excel Download

Cardiovascular risk factors associated to Familial Combined Hyperlipoproteinemia (FCHL) early cardiovascular complication rate: a retrospective case-control study on 867 subjects
Nutrition, Metabolism and Cardiovascular Diseases. 2004;14(5):304   Crossref logo
Link1 Link2

Role of the superposition of Metabolic Syndrome (MS) features on Familial Combined Hyperlipoproteinemia (FCHL) cardiovascular complication rate: a case-control study
Nutrition, Metabolism and Cardiovascular Diseases. 2004;14(5):304   Crossref logo
Link1 Link2

W01.123 Apolipoprotein AV gene polymorphism participates in familial combined hyperlipoproteinemia
Atherosclerosis. 2004;5(1):28   Crossref logo
Link1 Link2

A case of pseudohomozygous type II hyperlipoproteinemia in early infancy
Pediatrics International. 2011;53(1):110-113   Crossref logo
Link1 Link2

29 familial combined hyperlipoproteinemia (FCH) classified according to apolipoprotein E (APO E) phenotype
Clinical Biochemistry. 1985;18(3):206   Crossref logo
Link1 Link2

W01.123 Apolipoprotein AV gene polymorphism participates in familial combined hyperlipoproteinemia
Atherosclerosis Supplements. 2004;5(1):28   Crossref logo
Link1 Link2

Combined hyperlipoproteinemia Evidence for a new lipoprotein phenotype
Atherosclerosis. 1974;20(1):51-64   Crossref logo
Link1 Link2

Changes in plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after atorvastatin
Atherosclerosis. 2016;252:e45   Crossref logo
Link1 Link2

Changes in LCAT and CETP in subject with combined familiar hyperlipoproteinemia treated with ciprofiibrate
Atherosclerosis Supplements. 2001;2(2):93   Crossref logo
Link1 Link2

Effect of lipid-lowering therapy on lipid pattern variability of Familial Combined Hyperlipoproteinemia (FCHL) affected subjects
Nutrition, Metabolism and Cardiovascular Diseases. 2004;14(5):305   Crossref logo
Link1 Link2